Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 47 citing Bower: A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era.... (0.12 sec) 

AIDS-related malignancies: changing epidemiology and the impact of highly active …


M Bower, C Palmieri, T Dhillon - Current Opinion in Infectious Diseases, 2006 - journals.lww.com
Purpose of review Three cancers in people with HIV denote an AIDS diagnosis:
Kaposi's sarcoma, high-grade B-cell non- Hodgkin's lymphoma and invasive
cervical cancer. In addition a number of other cancers occur at increased ...
Cited by 66 - Related articles - BL Direct - All 4 versions

Primary treatment of Waldenstrom macroglobulinemia with dexamethasone, rituximab, and …

- ascopubs.org [PDF] 
… , A Anagnostopoulos, MC Kyrtsonis, K Zervas, … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org
American Society of Clinical Oncology Clinical Evidence ... Review on the
Ongoing Care of Adult Cancer Survivors: ... Joseph R. Carver, Charles L.
Shapiro, Andrea Ng, Linda Jacobs, Cindy Schwartz, Katherine S. Virgo, Karen ...
Cited by 34 - Related articles - All 9 versions

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly …

- jcojournal.org
ST Lim, R Karim, A Tulpule, BN Nathwani, AM … - Journal of Clinical Oncology, 2005 - jcojournal.org
PURPOSE: To compare the prognostic factors for survival and the validity of the
International Prognostic Index (IPI) in patients with HIV-related diffuse
large-cell lymphoma (HIV-DLCL) treated with curative intent in the ...
Cited by 34 - Related articles - All 8 versions

A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active …


J Stebbing, A Sanitt, M Nelson, T Powles, B … - The Lancet, 2006 - Elsevier
In the primary model, we developed a prognostic score from 0 to 15 starting at
10. Having Kaposi's sarcoma as the AIDS-defining illness (−3 points) and
increasing CD4 count (−1 point for every complete 100 cells per mm 3 ) ...
Cited by 32 - Related articles - All 18 versions

Modern management of non-Hodgkin lymphoma in HIV-infected patients.

- hem-aids.ru [PDF] 
N Mounier, M Spina, C Gisselbrecht - British journal of haematology, 2007 - pt.wkhealth.com
Patients infected with human immunodeficiency virus (HIV) are at greater risk of
developing non-Hodgkin lymphoma than the general population and aggressive
B-cell lymphoma has become one of the most common of the initial acquired ...
Cited by 20 - Related articles - BL Direct - All 9 versions

Acquired immunodeficiency syndrome-related lymphoma Simultaneous treatment with combined …


R Weiss, P Mitrou, K Arasteh, D Schuermann, … - CA A Cancer Journal for Clinicians - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 17 - Related articles - BL Direct - All 4 versions

Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology …

- ascopubs.org
EY Chiao, TP Giordano, P Richardson, HB El … - Journal of Clinical Oncology, 2008 - jco.ascopubs.org
Results In our cohort, 175 patients (15%) were HIV positive. The median age of
the HIV-negative and -positive patients was 63 and 49 years, respectively (P <
.001). Individuals with HIV were eight times more likely to be male (P = ...
Cited by 19 - Related articles - All 6 versions

Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab …


JM Ribera, A Oriol, M Morgades, E Gonzalez- … - British Journal of Haematology, 2008 - ingentaconnect.com
Immunochemotherapy with cyclophosphamide, adriamycin, vincristine, prednisone
and rituximab (R-CHOP) is the standard treatment in non-immunosuppressed
patients with diffuse large B-cell lymphoma (DLBCL), but its adequacy has ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Dose-Reduced Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation …


TR Spitzer, RF Ambinder, JY Lee, LD Kaplan … - Biology of Blood and Marrow Transplantation, 2008 - Elsevier
Intensive chemotherapy for human immunodeficiency virus (HIV)-associated
non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) has resulted in durable
remissions in a substantial proportion of patients. High-dose chemotherapy ...
Cited by 15 - Related articles - All 10 versions

Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and …

- pubget.com [PDF] 
P Miralles, J Berenguer, JM Ribera, R Rubio, B … - JAIDS Journal of Acquired Immune Deficiency …, 2007 - journals.lww.com
From the *Hospital Gregorio Marañón, Madrid, Spain; †Hospital Germans Trias
i Pujol, Badalona, Spain; ‡Hospital 12 de Octubre, Madrid, Spain; §Agencia
Ensayos Clínicos, Grupo de Estudio del SIDA, Sociedad Española de ...
Cited by 12 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google